Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | BCHE | P06276 | 1/20 | 0.60 |
| ▸ | CFTR | P13569 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | ACHE | P22303 | 1/20 | 0.60 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL840083 | 0.94 | MEN1 (0.59) | ALDH1A1KDM4EUSP2CYP1A2BCHE | |
| SCHEMBL10830714 | 0.93 | MEN1 (0.62) | ALDH1A1KDM4EUSP2CYP1A2BCHE | |
| Hydrochloric Acid SCHEMBL11644774 | 0.91 | MEN1 (0.60) | ALDH1A1KDM4EUSP2CYP1A2BCHE | |
| SCHEMBL8355374 | 0.88 | GRM2 (0.50) | ALDH1A1KDM4EUSP2CYP1A2BCHE | |
| SCHEMBL30842144 | 0.86 | KDM4E (0.50) | ALDH1A1KDM4EUSP2CYP1A2BCHE | |
| SCHEMBL21202394 | 0.83 | ALDH1A1 (0.48) | ALDH1A1KDM4EUSP2CYP1A2BCHE | |
| SCHEMBL30842160 | 0.81 | MEN1 (0.54) | ALDH1A1KDM4EUSP2CYP1A2BCHE | |
| SCHEMBL30842173 | 0.81 | MEN1 (0.51) | ALDH1A1KDM4EUSP2CYP1A2BCHE | |
| SCHEMBL18781843 | 0.80 | ALDH1A1 (0.44) | ALDH1A1KDM4EUSP2CYP1A2BCHE | |
| SCHEMBL11427510 | 0.79 | HTR2C (0.51) | ALDH1A1KDM4EUSP2CYP1A2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117727527-A | Magnetic semi-fluid composition and inductor | 深圳市优宝新材料科技有限公司 | 2024-03-19 | — | — | CN | claimed |
| EP-3331959-B1 | ANIONIC CURABLE COMPOSITIONS | DESIGNER MOLECULES INC (US) | 2022-10-05 | — | — | EP | claimed |
| US-20220204696-A1 | PHENOLIC FUNCTIONALIZED POLYIMIDES AND COMPOSITIONS THEREOF | DESIGNER MOLECULES, INC | 2022-06-30 | — | — | US | claimed |
| CN-113808779-B | Low-temperature curing insulating medium slurry for chip resistor | 西安宏星电子浆料科技股份有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-113808779-A | Low-temperature curing insulating medium slurry for chip resistor | 西安宏星电子浆料科技股份有限公司 | 2021-12-17 | — | — | CN | claimed |
| CN-108291122-B | Anionically curable compositions | 设计分子有限公司 | 2021-01-05 | — | — | CN | claimed |
| WO-2020219852-A1 | PHENOLIC FUNCTIONALIZED POLYIMIDES AND COMPOSITIONS THEREOF | DESIGNER MOLECULES, INC. (US) | 2020-10-29 | — | — | WO | claimed |
| CN-111763403-A | Liquid epoxy resin composition and preparation method and application thereof | 深圳先进电子材料国际创新研究院 | 2020-10-13 | — | — | CN | claimed |
| US-20180237668-A1 | ANIONIC CURABLE COMPOSITIONS | DESIGNER MOLECULES, INC. | 2018-08-23 | — | — | US | claimed |
| EP-3331959-A1 | ANIONIC CURABLE COMPOSITIONS | Designer Molecules, Inc. (US) | 2018-06-13 | — | — | EP | claimed |
| WO-2017027482-A1 | ANIONIC CURABLE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2017-02-16 | — | — | WO | claimed |
| WO-2012123403-A1 | EPOXY RESIN SYSTEM WITH VISUAL MONITORING OF THE HARDENING STATE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) | 2012-09-20 | — | — | WO | claimed |
| EP-2173747-B1 | A REGIOSELECTIVE METAL CATALYZED SYNTHESIS OF ANNELATED BENZIMIDAZOLES AND AZABENZIMIDAZOLES | SANOFI SA (FR) | 2011-12-21 | — | — | EP | claimed |
| US-20100216988-A1 | Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles | SANOFI-AVENTIS (FR) | 2010-08-26 | — | — | US | claimed |
| EP-2173747-A1 | A REGIOSELECTIVE METAL CATALYZED SYNTHESIS OF ANNELATED BENZIMIDAZOLES AND AZABENZIMIDAZOLES | Sanofi-Aventis (FR) | 2010-04-14 | — | — | EP | claimed |
| WO-2009000412-A1 | A REGIOSELECTIVE METAL CATALYZED SYNTHESIS OF ANNELATED BENZIMIDAZOLES AND AZABENZIMIDAZOLES | SANOFI AVENTIS (FR) | 2008-12-31 | — | — | WO | claimed |
| US-20040077800-A1 | Composition for protective film, method of using the same, and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2004-04-22 | — | — | US | claimed |
| EP-3312211-B1 | CURABLE COMPOSITION, ADHESIVE SHEET, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING ADHESIVE SHEET, AND DEVICE | DAICEL CORP (JP) | 2026-05-27 | — | — | EP | disclosed |
| US-4104194-A | 1,2-FUSED 5- OR 6-MEMBERED 1,3-DINITROGEN HETEROCYCLIC COMPOUNDS AS ANTICORROSION AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-08-01 | — | — | US | disclosed |
| US-4048174-A | ANTI-CORROSION AGENTS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216988-A1 | Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles | AZI2, NIT2, NISCH | ALDH1A1 107/4885KDM4E 478/4885USP2 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.